We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid Detection Method Developed for Polymyxin-Resistant Enterobacteria

By LabMedica International staff writers
Posted on 01 Jun 2016
Print article
Image: Representative results of the rapid polymyxin NP [Nordmann/Poirel] test. Non-inoculated wells are shown as controls (first column). The rapid polymyxin NP test was performed with a reference colistin-susceptible isolate (second column) and with a reference colistin-resistant isolate (third column) in a reaction medium without (upper row) and with (lower row) colistin (Photo courtesy of the University of Fribourg).
Image: Representative results of the rapid polymyxin NP [Nordmann/Poirel] test. Non-inoculated wells are shown as controls (first column). The rapid polymyxin NP test was performed with a reference colistin-susceptible isolate (second column) and with a reference colistin-resistant isolate (third column) in a reaction medium without (upper row) and with (lower row) colistin (Photo courtesy of the University of Fribourg).
Among the most clinically significant multidrug-resistant bacteria are carbapenemase-producing Enterobacteriaceae, yet these bacteria usually remain susceptible to polymyxins, so interest in polymyxins has been renewed worldwide.

A rapid test has been developed that detects glucose metabolization associated with bacterial growth in the presence of a defined concentration of colistin or polymyxin B. The standard reference technique for determining susceptibility to polymyxins is broth microdilution, which requires fastidious attention and at least 24 hours to perform.

Microbiologists at the University of Fribourg (Switzerland) developed the rapid polymyxin Nordmann/Poirel (NP) test that detects bacterial growth in the presence of a defined concentration of a polymyxin. Bacterial growth detection (or absence) is based on carbohydrate metabolism. Acid formation associated with carbohydrate metabolism in Enterobacteriaceae can be observed through the color change of a pH indicator. This test is rapid taking less than two hours and easy to perform.

To evaluate the performance of the rapid polymyxin NP test, the team used 200 isolates collected from clinical samples worldwide. This collection included 135 Enterobacteriaceae isolates resistant to polymyxin: five isolates of intrinsically polymyxin-resistant species and 130 isolates of various enterobacterial species with acquired resistance to polymyxins. The rapid polymyxin NP test uses two reagents and solutions: stock solutions of polymyxins and rapid polymyxin NP solution.

The sensitivity and specificity of the rapid NP test were 99.3% and 95.4%, respectively, compared with the standard broth microdilution method. By reading the color change of the wells every hour, the scientists determined that final results were obtained two hours after incubation when the tray was incubated at 35 ± 2 °C under an ambient atmosphere. However, positive results with frank color change were obtained as early as one hour after incubation for Klebsiella spp. and Escherichia coli isolates. Half of the Enterobacter spp. isolates gave positive results within 60 minutes of incubation and the other half within 120 minutes.

The authors concluded that the new test is inexpensive, easy to perform, sensitive, specific, and can be completed in less than two hours. It could be useful in countries facing endemic spread of carbapenemase producers and for which polymyxins are last-resort drugs. The study was published in the June 2016 issue of the journal Emerging Infectious Diseases.

Related Links:
University of Fribourg


New
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemistry Analyzer
AutoChem B861
New
Celiac Disease Test
AESKULISA tTg-A New Generation

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.